Stardust Power Inc.: Stardust Power Appoints Ray Rivers to Board of Directors

Stardust Power Inc. (NASDAQ: SDST) said it appointed V. Ray Rivers to its Board of Directors effective Aug. 10, 2026. He will also sit on the Audit and Compensation Committees, according to the company. The release highlights his 30+ years in capital markets and public company governance. The firm is building a battery-grade lithium carbonate refinery in Oklahoma with planned capacity up to 50,000 metric tons per year.

Original reporting
Published Aug 11, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 12:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stardust Power Inc.: Stardust Power Appoints Ray Rivers to Board of Directors — source image
Decision brief

The 30-second read

$SDSTNeutralLow
01

Why it matters

The governance update can modestly improve perceived oversight, but the release does not provide new operational metrics, funding, or commercial milestones that would change valuation materially.

02

Market read

For SDST, this is a governance/board composition update with limited immediate trading implications absent new financial or operational disclosures.

03

What to watch

Traders may be overlooking that the article includes no details on committee changes, audit findings, compensation policy, or any linked corporate action.

Relevance 4/10Novelty 3/10Timing: effective Aug. 10, 2026, announced Aug. 11 pre-market/regular session window

Background

Stardust Power is developing a battery-grade lithium carbonate refinery in Muskogee, Oklahoma, and this release announces a new independent board member with audit and compensation committee duties.

Company-level read

Ticker impact

$SDSTNeutralMedium confidence
Context

Stardust Power appointed V. Ray Rivers to its board, effective Aug. 10, 2026, with roles on the audit and compensation committees.

Expected impact

Likely limited, with any move driven by general governance sentiment rather than new fundamentals.

Evidence & confidence

The article is a routine director appointment. It provides background on the appointee but no new refinery capacity, financing, customer, regulatory, or earnings information.

Market effects

Minor governance signal for US battery-lithium refining peers, but no direct read-across catalyst is provided.

No specific Oklahoma/Muskogee operational update beyond general project description.

No global lithium price or trade-policy development is disclosed.

Counterpoint

The appointment may be largely ceremonial, with no immediate impact on permitting, offtake, or financing that would move the stock.

Key entities

  • Stardust Power Inc.

    NASDAQ-listed developer of battery-grade lithium carbonate, announcing a board appointment.

  • V. Ray Rivers

    New board member, also assigned to the Audit Committee and Compensation Committee.

  • Roshan Pujari

    Founder and CEO who comments on the appointment.

Related articles

$SDSTMed

Stardust Power signs lithium supply deal with Charge CCCV

Stardust Power (NASDAQ: SDST) said it signed a non-binding Letter of Intent with battery technology firm Charge CCCV LLC (C4V) to supply battery-grade lithium carbonate from its Muskogee, Oklahoma refinery. C4V’s preliminary demand forecast calls for 3,000 MT in 2028, 10,000 MT in 2029, and 20,000 MT by 2030. Stardust noted the deal could cover much of planned output and generate billions if prices stay near current levels.

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

$AZNMedAI 8/10

AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss

AstraZeneca's breast cancer drug camizestrant (Etcamah) failed to meet the primary endpoint in the Phase III SERENA-4 trial, missing a key growth opportunity. The trial showed no statistically significant improvement in progression-free survival. AstraZeneca's shares fell 3% in after-hours trading. The drug remains approved for ESR1-mutated patients, with strong Phase III data supporting this indication. AstraZeneca's overall oncology portfolio and pipeline remain robust, with first-half 2026 re

$LHXHigh

L3Harris Is Down 30% and Guggenheim Calls It a Buy

L3Harris Technologies (LHX) gained 0.43% premarket after Guggenheim initiated coverage with a Buy rating and $365 price target, suggesting 49% upside. The stock is near its 52-week low, down 30% in six months. Guggenheim expects sustained growth and defense spending tailwinds. Jefferies started coverage at Hold with a $315 target, citing leadership changes and missile IPO uncertainty.

$ABNBMedAI 8/10

Airbnb attempts to flip affordability script with $250M housing fund

Airbnb announced a $250 million fund to support affordable and mixed-income housing projects, according to the Wall Street Journal. The company aims to address criticism over its role in housing affordability. Funds will be distributed as gap financing, with the first project in Austin, Texas, receiving $6.4 million. Airbnb expects below-market returns but anticipates the investment will leverage $5 billion in capital over a decade. The initiative is led by former Biden administration official D